(90 days)
IMed Technology Intravascular administration sets and Imed Technology Extension sets intended use is to deliver sterile, infusion fluid from a container to the patient with or without flow control features. IMed Technology infusion tubing may act as an extension of other infusion tubing in delivering intravenous fluids from a container to patient.
IMed Technology, Intravascular administration/extension set is sterile, non-pyrogenic, non-DEHP PVC tubing with the following combination of components.
a. Universal Spike. Universal spike is constructed from ABS material and has a hydrophobic vent for transfer of fluids from closed containers such as infusion bottles. The spike dimensions are variable to deliver fluid at 10, 15, 20 and 60 drops per ml. Alternatively, the spike may have a luer lock at one end which connects to non-DEHP tubing for the purposes of transporting intravenous fluids from a vial to the patient.
b. Drip chamber with 15 micron filter. The drip chamber is constructed from non-DEHP PVC or EVA, is flexible and has inbuilt 15 micron particulate disc filter which filters solution passing through it.
c. Non-DEHP PVC tubing. Variable length non-DEHP PVC tubing with differing ID/OD combinations to ensure tubing performance. Extension tubing shall have ID/OD combinations of 0.03"/0.05" (minibore), 0.01"/0.03" (microbore), various lengths; 7" to 60". Infusion tubing shall have ID of 0.1" and OD of 0.125". Various combinations of the above tubing shall be designed to deliver desired performance.
d. Flow Regulator. A commercially available dial type flow regulator may be incorporated in-line to control the flow rate of infusion fluids. The flow regulator will provide standard graduations of 5ml/hr to a maximum of 250ml/hr. The flow regulator shall be constructed from medical grade ABS and medical grade silicone disc. Optionally, a rate restricted tubing may be also incorporated in the infusion set whereby the ID and length of the tubing has been calibrated to provide a specific flow rate at gravity pressure from liquid height of 36-40"
e. Roller clamp. A roller clamp may be inserted in combination with the above components to control flow rate or to turn fluid flow on and off. Roller clamp shall be constructed from medical grade ABS plastic
f. Slide clamp. A slide clamp may be inserted in combination with the above components to turn the fluid flow on and off. Slide clamp shall be constructed from medical grade ABS material.
g. Luer locks. Female luer locks and male luer locks may be a part of the infusion set as required and shall be constructed from medical grade ABS or non-DEHP hard PVC or medical grade PP.
h. Filters. In-line air eliminating filters may be incorporated into the infusion tubing. These filters will have pore size of 0.2 micron or 1.2 micron and shall be constructed from medical grade PVC or medical grade ABS and cellulose acetate membrane.
i. "Y" site (not made with natural rubber latex) or pre-approved needleless "Y" site for secondary infusions or medication administration. The "Y" site shall be integrated in combination with the above components and shall be constructed from hard PVC or PP or ABS (all components are medical grade). In case of an "injection port" (not made with natural rubber latex), the material shall be medical grade silicone.
The provided text does not describe an AI/ML-driven medical device, but rather a standard medical device, the "IMed Technology Intravascular Administration Sets and Imed Technology Extension Set." Therefore, much of the requested information regarding AI/ML studies (like MRMC studies, training set details, and expert ground truth establishment for AI) is not applicable.
However, I can extract the acceptance criteria and the study type conducted to demonstrate the device meets these criteria based on the provided FDA 510(k) summary.
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria Category | Specific Criteria | Reported Device Performance |
|---|---|---|
| Intended Use | Deliver sterile, infusion fluid from container to patient with or without flow control features. | Substantially Equivalent to predicate, meets intended use. |
| Design and Materials | Materials of construction are equivalent to predicate. | Exact same materials as predicate. |
| Labeling | Compliant with 21CFR807.87. | Compliant with 21CFR807.87 and Guidance Document. |
| Biocompatibility | Meets requirements for ISO 10993-1, External Communicating Device, Blood Path Indirect, Contact Duration A. | Meets requirements. |
| Bench Testing | USP Physicochemical tests for plastics and performance testing compliant with ISO Standards. | Compliant with USP Physicochemical tests and ISO Standards. |
| Sterilization | Sterility assurance level of 10^-6. | Achieves sterility assurance level of 10^-6. |
| ISO 8536-4:2010 tests for Intravascular Administration sets | Meets the acceptance criteria as specified in ISO 8536-4: 2010. | Meets the acceptance criteria. |
2. Sample size used for the test set and the data provenance:
The document mentions "performance testing compliant with ISO Standards" and "ISO 8536-4:2010 tests." However, it does not specify the sample size for these tests. The data provenance is also not explicitly stated beyond being part of a medical device submission to the FDA. Given the nature of a 510(k) for a physical medical device, these would typically be bench tests conducted by the manufacturer or a contract laboratory.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not applicable as this is a physical medical device (intravascular administration set) undergoing bench testing and not an AI/ML device where expert interpretation/consensus is used to establish ground truth for algorithm performance.
4. Adjudication method for the test set:
This is not applicable for a physical medical device undergoing bench testing against ISO standards. Adjudication methods are typically relevant for human interpretation tasks or AI model outputs that require expert review.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
This is not applicable. This is a physical medical device, not an AI/ML system, so no MRMC study involving human readers or AI assistance would have been performed.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
This is not applicable. This describes a physical medical device, not an algorithm.
7. The type of ground truth used:
The ground truth used for this device's evaluation is primarily engineering specifications and established international standards (e.g., ISO 8536-4:2010, ISO 10993-1) and USP Physicochemical tests. These standards define the expected performance characteristics, material properties, and safety requirements. The device's performance is measured against these objective criteria rather than expert consensus or pathology in a clinical context.
8. The sample size for the training set:
This is not applicable. This is a physical medical device, not an AI/ML system that requires a "training set."
9. How the ground truth for the training set was established:
This is not applicable for the same reason as point 8.
{0}------------------------------------------------
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 28, 2015
Imed Technology, Inc. Mr. Kyle Adams President 2544 Tarpley Rd., Suite 112 Carrollton, Texas 75006
Re: K150513
Trade/Device Name: Imed Technology Intravascular Administration Sets and Imed Technology Extension Set Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: FPA Dated: January 28, 2015 Received: February 27, 2015
Dear Mr. Adams:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Page 2 - Mr. Kyle Adams
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tina Kiang -S
for Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known):__K150513
Device Name: I Med Technology Intravascular Administration Set and Imed Technology Extension sets
Indications For Use: IMed Technology Intravascular administration set and Imed Technology Extension sets intended use is to deliver sterile, infusion fluid from a container to the patient with or without flow control features. IMed Technology infusion tubing may act as an extension of other infusion tubing in delivering intravenous fluids from a container to patient.
Prescription Use ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
{3}------------------------------------------------
IMed Technology, LLC
| Date Submitted: | May 1, 2015 |
|---|---|
| Submitted By: | iMed Technology, Inc2515 Tarpley Road, Suite 104Carrollton, TX 75006Tel: 972-732-7333Contact email: kyle.adams@imedtechnology.com |
| Subject Device Name: | Imed Technology Intravascular Administration setsand Imed Technology Extension sets |
| Common Name of Device: | Intravascular Administration Set |
| Predicate Device: | Acta Medical Intravascular Administration Set (K121803) |
| Panel: | General Hospital and Personal Use |
| Product Code: | FPA |
| Device Classification: | 21 CFR880.5440, Class II |
{4}------------------------------------------------
Name & Model Numbers of Devices.
-
- IMEDINF01, Intravascular administration set
-
- IMEDINF02, Intravascular administration set with 0.2 micron filter
-
- IMEDINF03, Intravascular administration set with flow regulator
-
- IMEDINF04, Intravascular administration set with flow regulator, 0.2 micron filter
-
- IMEDEXT01, Minibore extension set
Other Model Numbers and configurations may be assembled per customer request
Device Classification
- Set, Administration, Intravascular a.
- b. FPA
- 21CFR880.5440 C.
- d. Device Classification II
Indications For Use
IMed Technology Intravascular administration sets and Imed Technology Extension sets intended use is to deliver sterile, infusion fluid from a container to the patient with or without flow control features. IMed Technology infusion tubing may act as an extension of other infusion tubing in delivering intravenous fluids from a container to patient.
Device Description
IMed Technology, Intravascular administration/extension set is sterile, non-pyrogenic, non-DEHP PVC tubing with the following combination of components.
- Universal Spike. Universal spike is constructed from ABS material and has a a. hydrophobic vent for transfer of fluids from closed containers such as infusion bottles. The spike dimensions are variable to deliver fluid at 10, 15, 20 and 60 drops per ml. Alternatively, the spike may have a luer lock at one end which connects to non-DEHP tubing for the purposes of transporting intravenous fluids from a vial to the patient.
- Drip chamber with 15 micron filter. The drip chamber is constructed from nonb. DEHP PVC or EVA, is flexible and has inbuilt 15 micron particulate disc filter which filters solution passing through it.
- Non-DEHP PVC tubing. Variable length non-DEHP PVC tubing with differing C. ID/OD combinations to ensure tubing performance. Extension tubing shall have ID/OD combinations of 0.03"/0.05" (minibore), 0.01"/0.03" (microbore), various lengths; 7" to 60". Infusion tubing shall have ID of 0.1" and OD of 0.125". Various combinations of the above tubing shall be designed to deliver desired performance.
{5}------------------------------------------------
- d. Flow Regulator. A commercially available dial type flow regulator may be incorporated in-line to control the flow rate of infusion fluids. The flow regulator will provide standard graduations of 5ml/hr to a maximum of 250ml/hr. The flow regulator shall be constructed from medical grade ABS and medical grade silicone disc. Optionally, a rate restricted tubing may be also incorporated in the infusion set whereby the ID and length of the tubing has been calibrated to provide a specific flow rate at gravity pressure from liquid height of 36-40"
- e. Roller clamp. A roller clamp may be inserted in combination with the above components to control flow rate or to turn fluid flow on and off. Roller clamp shall be constructed from medical grade ABS plastic
- f. Slide clamp. A slide clamp may be inserted in combination with the above components to turn the fluid flow on and off. Slide clamp shall be constructed from medical grade ABS material.
- g. Luer locks. Female luer locks and male luer locks may be a part of the infusion set as required and shall be constructed from medical grade ABS or non-DEHP hard PVC or medical grade PP.
- h. Filters. In-line air eliminating filters may be incorporated into the infusion tubing. These filters will have pore size of 0.2 micron or 1.2 micron and shall be constructed from medical grade PVC or medical grade ABS and cellulose acetate membrane.
- i. "Y" site (not made with natural rubber latex) or pre-approved needleless "Y" site for secondary infusions or medication administration. The "Y" site shall be integrated in combination with the above components and shall be constructed from hard PVC or PP or ABS (all components are medical grade). In case of an "injection port" (not made with natural rubber latex), the material shall be medical grade silicone.
Specification & Dimensions
IMed Technology, Intravascular Administration Set will have the following dimensional specifications:
- a. Infusion tubing OD = 4.1mm, ID = 3.0mm (approximately)
- b. Extension tubing regular bore OD = 2.7mm, ID = 1.6mm (approximately)
- c. Extension tubing minibore OD = 2.0mm, ID = 1.0mm (approximately)
- d. Extension tubing microbore OD = 1.6mm. ID = 0.6mm (approximately)
- e. Additional custom dimensions may be manufactured for customers
- f. Length may vary from 5" for extension set to 105" for primary infusion set
Materials
Acrylonitrile Butadiene Styrene Non-DEHP Poly Vinyl Chloride Polypropylene (non fluid pathway material, utilized in protective caps only) Silicone
{6}------------------------------------------------
COMPARISON TABLE
IMed Technology Intravascular Administration Set Comparison To Acta Medical Intravascular Administration Set (K121803)
| Feature | Details | Predicate DeviceK121803 | Conclusion |
|---|---|---|---|
| Intended Use | IMedTechnology,IntravascularAdministrationset intended useis to deliversterile, infusionfluid from acontainer to thepatient with orwithout flowcontrol features. | Acta MedicalIntravascularAdministration setintended use is todeliver sterile,infusion fluid from acontainer to thepatient with orwithout flow controlfeatures. | SubstantiallyEquivalent |
| Design and Materialsof Construction | The materials ofconstruction for theproposed device areexactly the same as thematerials for thepredicate product | The design andmaterials ofconstruction remainthe same as thepredicate product. | SubstantiallyEquivalent |
| Labeling | Compliant with21CFR807.87 | Compliant with21CFR807.87 | SubstantiallyEquivalent |
| Biocompatibility | Meets requirements forISO 10993-1, ExternalCommunicating Device,Blood Path Indirect,Contact Duration A | Meets requirementsfor ISO 10993-1,ExternalCommunicatingDevice, Blood PathIndirect, ContactDuration A | SubstantiallyEquivalent |
| Bench Testing | USP Physicochemicaltests for plastics andperformance testingcompliant with ISOStandards | USPPhysicochemicaltests for plastics andperformance testingcompliant with ISOStandards | SubstantiallyEquivalent |
| Sterilization | Sterility assurance levelof 10-6 | Sterility assurancelevel of 10-6 | SubstantiallyEquivalent |
| Labeling | As per Guidance Document | As per Guidance Document | Substantially Equivalent |
| ISO 8536-4:2010 testsfor IntravascularAdministration sets | Meets the acceptancecriteria as specified inISO 8536-4: 2010 | Meets theacceptance criteriaas specified in ISO8536-4: 2010 | SubstantiallyEquivalent |
{7}------------------------------------------------
Substantial Equivalence:
IMed Technology, Intravascular Administration Set is substantially equivalent to the predicate device, Acta Medical Intravascular Administration Set (K121803). The component materials, indication for use, SAL are substantially equivalent and present no additional concerns as compared to the predicate device.
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.